Insider Trading & Ownership - Cohen Yuval

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Cohen Yuval
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-08-10
Purchase
2022-08-11
09:55 am
Corbus Pharmaceuticals Holdings Inc.CRBPCohen Yuval
Chief Executive Officer
3,800$0.264$1,00398,230
(Direct)
View
2022-05-16
Purchase
2022-05-16
10:41 am
Corbus Pharmaceuticals Holdings Inc.CRBPCohen Yuval
Chief Executive Officer
10,500$0.25$2,62594,430
(Direct)
View
2022-03-09
Purchase
2022-03-09
10:37 am
Corbus Pharmaceuticals Holdings Inc.CRBPCohen Yuval
Chief Executive Officer
8,600$0.37$3,18283,930
(Direct)
View
2020-11-11
Purchase
2020-11-12
10:28 am
Corbus Pharmaceuticals Holdings Inc.CRBPCohen Yuval
Chief Executive Officer
4,240$1.209$5,12675,330
(Direct)
View
2020-03-17
Purchase
2020-03-17
1:14 pm
Corbus Pharmaceuticals Holdings Inc.CRBPCohen Yuval
Chief Executive Officer
4,300$3.49$15,00771,090
(Direct)
View
2019-11-12
Purchase
2019-11-12
1:02 pm
Corbus Pharmaceuticals Holdings Inc.CRBPCohen Yuval
Chief Executive Officer
1,430$4.26$6,09266,790
(Direct)
View
2019-08-12
Purchase
2019-08-12
10:37 am
Corbus Pharmaceuticals Holdings Inc.CRBPCohen Yuval
Chief Executive Officer
1,175$6.056$7,11665,360
(Direct)
View
2019-05-13
Purchase
2019-05-14
09:47 am
Corbus Pharmaceuticals Holdings Inc.CRBPCohen Yuval
Chief Executive Officer
995$6.9898$6,95564,185
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-12
Option Award
2024-02-14
3:19 pm
N/A
2034-02-12
Corbus Pharmaceuticals Holdings Inc.CRBPCohen Yuval
Chief Executive Officer
73,947$0158,347
(Direct)
View
2024-01-26
Exercise
2024-01-30
4:56 pm
2014-02-28
2014-01-29
Corbus Pharmaceuticals Holdings Inc.CRBPCohen Yuval
Chief Executive Officer
7,179$4.977,179
(Direct)
View
2023-02-13
Option Award
2023-02-15
12:44 pm
N/A
2033-02-13
Corbus Pharmaceuticals Holdings Inc.CRBPCohen Yuval
Chief Executive Officer
1,989,546$01,949,546
(Direct)
View
2022-02-01
Option Award
2022-02-02
5:51 pm
N/A
2032-02-01
Corbus Pharmaceuticals Holdings Inc.CRBPCohen Yuval
Chief Executive Officer
1,489,700$01,489,700
(Direct)
View
2021-02-02
Option Award
2021-02-04
4:35 pm
N/A
2031-02-02
Corbus Pharmaceuticals Holdings Inc.CRBPCohen Yuval
Chief Executive Officer
1,913,000$01,913,000
(Direct)
View
2020-03-06
Option Award
2020-03-09
5:31 pm
N/A
2030-03-06
Corbus Pharmaceuticals Holdings Inc.CRBPCohen Yuval
Chief Executive Officer
639,000$0639,000
(Direct)
View